On Jun. 27, PEN LEG passed bill re coverage for biomarker testing.
PEN LEG passed bill HB 1754 to amend The Insurance Company Law of 1921, act of May 17, 1921, P.L. 682 No. 284, which provides for coverage for biomarker testing.
Bill Provisions
The coverage will be required for diagnosis, testing, management and monitoring of a patient's disease or condition, and administered similar to other health care services.
Indicates terms for medical assistance or children's health insurance program managed care plan that provides biomarker testing, and biomarker related definitions.
Legislative History
On Jun. 3, 2024, bill introduced in House; on Jun. 10, 2024, bill was passed in House.
On Jun. 10, 2024, bill delivered to the Senate; on Jun. 25, 2024, bill passed in Senate.
On Jun. 27, 2024, bill was presented to the governor, pending action by the governor.
Effectiveness
For medical assistance, children's health insurance program managed care plans, new section will apply Jan. 1, 2026, and overall, will take effect in 180 days, if enacted.
